Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy

BACKGROUND: The use of immune checkpoint inhibitors (ICI) is associated with cardiovascular (CV) events, and patients with pre-existing autoimmune disease are at increased CV risk. OBJECTIVES: The aim of this study was to characterize the risk for CV events in patients with pre-existing autoimmune d...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Charlotte, Drobni, Zsofia D., Zafar, Amna, Gongora, Carlos A., Zlotoff, Daniel A., Alvi, Raza M., Taron, Jana, Rambarat, Paula K., Schoenfeld, Sara, Mosarla, Ramya C., Raghu, Vineet K., Hartmann, Sarah E., Gilman, Hannah K., Murphy, Sean P., Sullivan, Ryan J., Faje, Alexander, Hoffmann, Udo, Zhang, Lili, Mayrhofer, Thomas, Reynolds, Kerry L., Neilan, Tomas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830202/
https://www.ncbi.nlm.nih.gov/pubmed/36636443
http://dx.doi.org/10.1016/j.jaccao.2022.11.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830202/
https://www.ncbi.nlm.nih.gov/pubmed/36636443
http://dx.doi.org/10.1016/j.jaccao.2022.11.008

Ejemplares similares